A new report shows that the number of FDA approvals for cancer drugs has shot up in the last few decades. What’s behind the rise?
A wave of incoming anti-inflammatories and gene therapies that could make it big
Last year, the FDA once again set a new record for new drug approvals and far surpassed its 10-year average.
Premature promises about cell therapies create expectations ripe for disappointment